Concepedia

Katharine L. Chu

KL

Statistics

Publications

30

Citations

2.7K

H-Index

22

Active since

2001

Affiliations

Abbott Fund(Current)

Abbott (United States)

AbbVie (United States)

Abbott (United Kingdom)

Discovery Laboratories (United States)

Katharine L. Chu is an author at Abbott Fund specializing in medicine, health sciences, and pain research.

Top concepts

Publications per year

2001–2018

30

Publications

30

A-803467, a potent and selective Na <sub>v</sub> 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

Michael F. Jarvis, Prisca Honoré, Char‐Chang Shieh et al. · Proceedings of the National Academy of Sciences · 2007 · 514 citations · Full text

A-317491, a novel potent and selective non-nucleotide antagonist of P2X <sub>3</sub> and P2X <sub>2/3</sub> receptors, reduces chronic inflammatory and neuropathic pain in the rat

Michael F. Jarvis, Edward C. Burgard, Steve McGaraughty et al. · Proceedings of the National Academy of Sciences · 2002 · 458 citations · Full text

Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation

Jun Chen, Shailen K. Joshi, Stanley DiDomenico et al. · Pain · 2011 · 269 citations · Full text

TRPA1 Modulation of Spontaneous and Mechanically Evoked Firing of Spinal Neurons in Uninjured, Osteoarthritic, and Inflamed Rats

Steve McGaraughty, Katharine L. Chu, Richard J. Perner et al. · Molecular Pain · 2010 · 192 citations · Full text

Effects of A‐317491, a novel and selective P2X<sub>3</sub>/P2X<sub>2/3</sub> receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration

Steve McGaraughty, Carol T. Wismer, Chang Zhu et al. · British Journal of Pharmacology · 2003 · 177 citations · Full text

1–5 of 30